Univest
Univest
  • Markets

Tatva Chintan Pharma Chem Ltd. (TATVA) Share Price Hits Fresh 52-Week High at Rs 1,898.25

  • October 7, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Tatva Chintan Pharma Chem Ltd. Share Price
Tatva Chintan Pharma Chem Ltd. (TATVA) share price reached a fresh 52-week high of Rs 1,898.25 today and later stood at Rs 1,880, down 0.22% from the previous close. Market cap was Rs 4,187.88 crore.

Tatva Chintan Pharma Chem Ltd. Share Price is in focus after the stock touched a fresh 52-week high of Rs 1,898.25 and was last traded at Rs 1,880, down Rs 4.15 or 0.22% from the previous close of Rs 1,884.15. Market capitalisation stood at Rs 4,187.88 crore as of 07 October 2026 at 9:22 AM IST. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. For readers tracking Tatva Chintan Pharma Chem Ltd. Share Price Today, the key point is the fresh yearly high itself, alongside a day range that extended from Rs 1,868.05 to Rs 1,898.25. The move places Tatva Chintan Pharma Chem Ltd. Share Price News squarely within 52 Week High Stocks and Stock Market Today screens.

Table of Contents

Toggle
  • Tatva Chintan Pharma Chem Ltd. Share Price Today: Price Action Analysis
  • Tatva Chintan Pharma Chem Ltd. (TATVA) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Tatva Chintan Pharma Chem Ltd.
  • About Tatva Chintan Pharma Chem Ltd.
  • Frequently Asked Questions
    • What is Tatva Chintan Pharma Chem Ltd. Share Price today?
    • Did Tatva Chintan Pharma Chem Ltd. Share Price hit a new 52-week high?
    • Why is Tatva Chintan Pharma Chem Ltd. Share Price in focus today?
    • What is the market capitalisation of Tatva Chintan Pharma Chem Ltd. Share Price?
    • How does Tatva Chintan Pharma Chem Ltd. Share Price compare on valuation?
    • What do the return ratios show for Tatva Chintan Pharma Chem Ltd. Share Price?
    • What are the key fundamentals behind Tatva Chintan Pharma Chem Ltd. Share Price?
    • How does Tatva Chintan Pharma Chem Ltd. Share Price compare with peers?
  • Track Tatva Chintan Pharma Chem Ltd. Share Price on Univest

Tatva Chintan Pharma Chem Ltd. Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 1,880
Previous Close Rs 1,884.15
Today's Move Rs -4.15 (-0.22%)
Open Rs 1,874.75
High Rs 1,898.25
Low Rs 1,868.05
Market Capitalisation Rs 4,187.88 crore

Tatva Chintan Pharma Chem Ltd. (TATVA) traded at Rs 1,880 versus the previous close of Rs 1,884.15, a fall of 0.22%. The stock opened at Rs 1,874.75, reached a high of Rs 1,898.25 and touched a low of Rs 1,868.05.

Tatva Chintan Pharma Chem Ltd. Share Price Today shows a narrow intraday move around the previous close, with the stock opening at Rs 1,874.75, touching Rs 1,898.25 and moving to a low of Rs 1,868.05. The current price of Rs 1,880 is slightly below the previous close of Rs 1,884.15, which leaves the day change at minus Rs 4.15 and minus 0.22%. The fresh 52-week high equals the day’s high, so the stock has already marked a one-year high in the current market session.

For anyone tracking Tatva Chintan Pharma Chem Ltd. Share Price Live, the relevant facts are simple: the range is tight, the yearly high is Rs 1,898.25, and the last traded price is still close to that mark. According to latest Univest figures, the price event is confirmed, but no company-specific catalyst is established. That makes the market action important on its own, without adding an explanation that is not in the record. Tatva Chintan Pharma Chem Ltd. Share Price therefore remains an event-led name in today’s Indian Stock Market and Share Market Today coverage.

Tatva Chintan Pharma Chem Ltd. (TATVA) Fundamental Analysis

Metric Value
Market Capitalisation Rs 4,187.88 crore
P/E Ratio 85.77x
P/B Ratio 5.52x
ROE 5.53%
ROCE 7.17%
EPS Rs 21.97
Book Value Per Share Rs 341.03
Dividend Yield 0.11%

Tatva Chintan Pharma Chem Ltd. (TATVA) fundamental metrics show P/E 85.77x, P/B 5.52x, ROE 5.53%, ROCE 7.17%. These figures provide context only and are not a buy or sell signal.

Tatva Chintan Pharma Chem Ltd. has a market capitalisation of Rs 4,187.88 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 85.77x, P/B at 5.52x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 5.53% and ROCE of 7.17%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 21.97, book value per share of Rs 341.03, dividend yield of 0.11%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 26.9x, median ROE of 7.87%, median ROCE of 10.04%. Taken together, they outline the fundamentals rather than a view on the stock.

Sector and Industry Context

Metric Value
Sector Chemicals
Industry Chemicals
Benchmark Scope same industry
Company P/E Ratio 85.77x
Benchmark Median P/E 26.9x
Benchmark Average P/E 50.65x
Benchmark P/E Range 5.08x to 742.21x
Company P/B Ratio 5.52x
Benchmark Median P/B 1.95x
Company ROE 5.53%
Benchmark Median ROE 7.87%
Company ROCE 7.17%
Benchmark Median ROCE 10.04%
Company Market Capitalisation Rs 4,187.88 crore
Benchmark Median Market Cap Rs 483.38 crore

Tatva Chintan Pharma Chem Ltd. (TATVA) operates in the Chemicals sector, within the Chemicals industry.

Tatva Chintan Pharma Chem Ltd. (TATVA) has a P/E ratio of 85.77x, which is above the benchmark median of 26.9x, a difference of +218.85%. On its own, the P/E gap is a valuation reference point, not a trading call.

Tatva Chintan Pharma Chem Ltd. (TATVA) has a ROE of 5.53%, which is below the benchmark median of 7.87%, a difference of -29.73%. Tatva Chintan Pharma Chem Ltd. (TATVA) has a ROCE of 7.17%, which is below the benchmark median of 10.04%, a difference of -28.59%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Vishnu Chemicals Ltd. VISHNU 4,359 31.23 4.22 14.26 16.38
Epigral Ltd. EPIGRAL 4,390.28 16.52 1.93 16.09 15.65
Gujarat Alkalies And Chemicals Ltd. GUJALKALI 4,442.93 68.22 0.86 -0.04 1.4
Grauer & Weil (India) Ltd. GRAUWEIL 3,782.36 23.3 3.33 16.23 21.55
Foseco India Ltd. FOSECOIND 4,728.42 67.27 4.51 10.87 15.35

Tatva Chintan Pharma Chem Ltd. (TATVA) has a P/E ratio of 85.77x compared with the displayed peer median of 31.23x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 5.53% compares with a peer median of 14.26% across the companies shown in the table. ROCE stood at 7.17% versus the displayed peer median of 15.65%, providing a capital-efficiency comparison. Tatva Chintan Pharma Chem Ltd. (TATVA) has a market capitalisation of Rs 4,187.88 crore. Among the 5 peers shown, 4 have a larger market capitalisation.

Why Investors Are Watching Tatva Chintan Pharma Chem Ltd.

  • Tatva Chintan Pharma Chem Ltd. Share Price touched a fresh 52-week high of Rs 1,898.25 and was last traded at Rs 1,880.
  • The day range for Tatva Chintan Pharma Chem Ltd. Share Price was Rs 1,868.05 to Rs 1,898.25.
  • Tatva Chintan Pharma Chem Ltd. Share Price has a market capitalisation of Rs 4,187.88 crore.
  • The company’s P/E ratio for Tatva Chintan Pharma Chem Ltd. Share Price is 85.77, above the industry median of 26.9.
  • ROE of 5.53% and ROCE of 7.17% for Tatva Chintan Pharma Chem Ltd. Share Price sit below the industry medians of 7.87% and 10.04%.

About Tatva Chintan Pharma Chem Ltd.

Tatva Chintan Pharma Chem Ltd. operates in the Chemicals sector and Chemicals industry. Tatva Chintan Pharma Chem Ltd. Share Price is followed as part of that industry classification, with the latest quarter revenue at Rs 167.06 crore for Jun 2026. The company’s valuation, market capitalisation and return ratios are the main verified fundamentals visible here, and they frame how Tatva Chintan Pharma Chem Ltd. Share Price is read on Univest.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

What is Tatva Chintan Pharma Chem Ltd. Share Price today?

Ans. Tatva Chintan Pharma Chem Ltd. Share Price was last traded at Rs 1,880, after touching a fresh 52-week high of Rs 1,898.25. The previous close was Rs 1,884.15, so the move for the current session is slightly lower.

Did Tatva Chintan Pharma Chem Ltd. Share Price hit a new 52-week high?

Ans. Yes. Tatva Chintan Pharma Chem Ltd. Share Price touched a fresh 52-week high of Rs 1,898.25 in the current session. The stock later traded at Rs 1,880, which is below that high but still near the day’s top.

Why is Tatva Chintan Pharma Chem Ltd. Share Price in focus today?

Ans. Tatva Chintan Pharma Chem Ltd. Share Price is in focus because it marked a fresh yearly high and carried a market capitalisation of Rs 4,187.88 crore. According to Univest data, the price event is confirmed, but no company-specific catalyst is established.

What is the market capitalisation of Tatva Chintan Pharma Chem Ltd. Share Price?

Ans. Tatva Chintan Pharma Chem Ltd. Share Price has a market capitalisation of Rs 4,187.88 crore. That places it close to several listed Chemicals peers in the same market-cap band, including Vishnu Chemicals, Epigral and Gujarat Alkalies and Chemicals.

How does Tatva Chintan Pharma Chem Ltd. Share Price compare on valuation?

Ans. Tatva Chintan Pharma Chem Ltd. Share Price has a P/E ratio of 85.77 and a P/B ratio of 5.52. Both are above the same-industry median levels of 26.9 and 1.95, respectively, within the Chemicals benchmark set.

What do the return ratios show for Tatva Chintan Pharma Chem Ltd. Share Price?

Ans. Tatva Chintan Pharma Chem Ltd. Share Price shows ROE of 5.53% and ROCE of 7.17%. Both are below the same-industry medians of 7.87% and 10.04%, which gives useful context for the valuation discussion.

What are the key fundamentals behind Tatva Chintan Pharma Chem Ltd. Share Price?

Ans. Tatva Chintan Pharma Chem Ltd. Share Price is linked to EPS of 21.97, book value of Rs 341.03 and dividend yield of 0.11%. The latest quarter revenue was Rs 167.06 crore for Jun 2026, adding another reference point.

How does Tatva Chintan Pharma Chem Ltd. Share Price compare with peers?

Ans. Tatva Chintan Pharma Chem Ltd. Share Price sits near peers such as Vishnu Chemicals and Epigral on market cap, but its P/E is higher than several names in the peer set. ROE and ROCE are also lower than some listed comparables.

Track Tatva Chintan Pharma Chem Ltd. Share Price on Univest

Use Tatva Chintan Pharma Chem Ltd. (TATVA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

You can track Tatva Chintan Pharma Chem Ltd. Share Price on Univest for live price updates, key fundamental ratios, 52-week levels, market cap context and company news. Univest also brings together Tatva Chintan Pharma Chem Ltd. Share Price Today, valuation checks and relevant market context in one place for faster monitoring.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply